Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126942362 | 12694236 | 2 | F | 20160902 | 20160829 | 20160909 | EXP | BE-PFIZER INC-2016395234 | PFIZER | VULSTEKE, C.. FIRST EVIDENCE OF TREATMENT EFFICACY IN METASTATIC CARCINOMA OF THE PAROTID GLAND WITH BRD4/NUT TRANSLOCATION. JOURNAL OF CHEMOTHERAPY. 2016;28 (2):242-246 | 32.00 | YR | M | Y | 0.00000 | 20160909 | MD | BE | BE |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126942362 | 12694236 | 1 | SS | CISPLATIN. | CISPLATIN | 1 | UNK (30-40 MG/M2) | U | 0 | ||||||||||
| 126942362 | 12694236 | 2 | SS | CISPLATIN. | CISPLATIN | 1 | U | 0 | |||||||||||
| 126942362 | 12694236 | 3 | PS | DOXORUBICIN HCL | DOXORUBICIN HYDROCHLORIDE | 1 | 20 MG/M2, UNK | 50467 | 20 | MG/M**2 | |||||||||
| 126942362 | 12694236 | 4 | SS | DOXORUBICIN HCL | DOXORUBICIN HYDROCHLORIDE | 1 | 50467 | ||||||||||||
| 126942362 | 12694236 | 5 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | 2000 MG/M2, (DAY 1-3 INCHES A THREE WEEKLY SCHEDULE) | U | 0 | 2000 | MG/M**2 | ||||||||
| 126942362 | 12694236 | 6 | SS | IFOSFAMIDE. | IFOSFAMIDE | 1 | U | 0 | |||||||||||
| 126942362 | 12694236 | 7 | C | DENOSUMAB | DENOSUMAB | 1 | UNK, MONTHLY | 0 | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126942362 | 12694236 | 1 | Metastases to bone |
| 126942362 | 12694236 | 2 | Salivary gland cancer |
| 126942362 | 12694236 | 3 | Metastases to bone |
| 126942362 | 12694236 | 4 | Salivary gland cancer |
| 126942362 | 12694236 | 5 | Metastases to bone |
| 126942362 | 12694236 | 6 | Salivary gland cancer |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126942362 | 12694236 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126942362 | 12694236 | Decreased appetite | |
| 126942362 | 12694236 | Febrile neutropenia | |
| 126942362 | 12694236 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |